Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1
- PMID: 2997790
- PMCID: PMC391358
- DOI: 10.1073/pnas.82.21.7429
Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1
Abstract
An Epstein-Barr virus (EBV) deletion mutant, HR-1, cannot immortalize lymphocytes. HR-1 was derived from a virus strain, Jijoye, that is immortalization competent. Using human antiserum from certain patients with chronic active EBV infection, we have identified in Jijoye cells a protein of apparent mass of 78-80 kDa that is missing in cells with the HR-1 genome. A protein of identical size and antigenicity has been stably expressed in mouse LTK- cells by gene transfer with cloned Jijoye EBV DNA that encompasses the deletion in the HR-1 genome. The expressed product is a nuclear neoantigen. The polypeptide we have identified is likely to be essential in the immortalization process.
Similar articles
-
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.J Virol. 1989 Apr;63(4):1531-9. doi: 10.1128/JVI.63.4.1531-1539.1989. J Virol. 1989. PMID: 2538644 Free PMC article.
-
An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.Proc Natl Acad Sci U S A. 1986 Sep;83(17):6641-5. doi: 10.1073/pnas.83.17.6641. Proc Natl Acad Sci U S A. 1986. PMID: 3018741 Free PMC article.
-
Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region.J Virol. 1982 Sep;43(3):952-68. doi: 10.1128/JVI.43.3.952-968.1982. J Virol. 1982. PMID: 6292473 Free PMC article.
-
Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency.Adv Cancer Res. 1992;58:1-26. doi: 10.1016/s0065-230x(08)60288-2. Adv Cancer Res. 1992. PMID: 1312289 Review. No abstract available.
-
Epstein-Barr virus (EBV), lymphocytes and transformation.J Cancer Res Clin Oncol. 1983;106(1):1-11. doi: 10.1007/BF00399890. J Cancer Res Clin Oncol. 1983. PMID: 6309856 Free PMC article. Review. No abstract available.
Cited by
-
Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment.J Virol. 1986 May;58(2):324-30. doi: 10.1128/JVI.58.2.324-330.1986. J Virol. 1986. PMID: 3009849 Free PMC article.
-
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences.J Virol. 1996 Jul;70(7):4829-33. doi: 10.1128/JVI.70.7.4829-4833.1996. J Virol. 1996. PMID: 8676517 Free PMC article.
-
Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.Cell Metab. 2019 Sep 3;30(3):539-555.e11. doi: 10.1016/j.cmet.2019.06.003. Epub 2019 Jun 27. Cell Metab. 2019. PMID: 31257153 Free PMC article.
-
Epstein-Barr virus-driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation.Sci Adv. 2025 Jan 31;11(5):eadr8837. doi: 10.1126/sciadv.adr8837. Epub 2025 Jan 29. Sci Adv. 2025. PMID: 39879311 Free PMC article.
-
Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes.J Virol. 1990 Jun;64(6):2866-75. doi: 10.1128/JVI.64.6.2866-2875.1990. J Virol. 1990. PMID: 2159547 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources